
NeuroProof Systems GmbH
Rostock, Germany neuroproof.com From their website, Nov 2026
Work here? Claim this listing
About
NeuroProof Systems GmbH is a contract research organization in Rostock, Germany that provides CNS drug screening services. It works for drug discovery and preclinical development projects using neuronal cell cultures, MEA recordings, and data analysis. It serves clients developing neuro-pharmaceuticals and neurotoxicity programs.
Services
Phenotypic screening
Functional phenotypic screening of compounds using neuronal cell cultures and MEA-based readouts.
Disease models
In vitro CNS disease models for neurodegenerative, neurological, psychotic, and rare diseases using primary and iPSC-derived neurons.
Neurotoxicity assessment
In vitro assays to assess acute, developmental, chronic, and drug-induced neurotoxicity.
Prediction of side effects
Screening assays to predict pro-convulsive, seizurogenic, and sedative side effects of compounds.
MEA recording services
Compound testing with microelectrode array recordings, including concentration-response curves, substance database comparison, long-term experiments, and synergy assessment.
Imaging
Automated imaging services for higher-throughput phenotypic screening.
Stem cell services
Screening and assay support with iPSC-derived neuronal cell cultures and stem cell-based neuronal systems.
Spike train analysis
Analysis of spike train data from MEA neurochips using proprietary tools and multivariate statistics.
13 more services
- Pattern recognition
- Molecular biology
- Neuronal maturation assays
- Cell viability and cytotoxicity assays
- Target validation
- Neurotoxicity
- Functional Phenotypic Screening
- Neuronal Maturation
- Biologics and AAV Testing
- Data Analysis Services
- Glutamate Excitotoxicity Assay
- Alzheimer’s Functional Phenotypic Disease Model
- Parkinson's Disease In Vitro Disease Models and PD Screening Assays
- What to send
- Neuronal cultures on MEA chips
- Primary neuronal cell cultures
- Human iPSC-derived cell cultures
- Primary mouse, rat, or human iPSC-derived neurons
Capabilities
- Assays and studies
- Rodent models
- High-content imaging
- AAV
- In vivo
- Small molecules
- Phenotypic screening
19 more
- Functional phenotypic screening
- MEA screening
- Spike train analysis
- Pattern recognition
- Neurotoxicity assays
- Acute neurotoxicity
- Developmental neurotoxicity
- Chronic toxicity
- Sedation prediction
- Pro-convulsive prediction
- Epilepsy assay
- ALS hyperexcitation assay
- Alzheimer Abeta assay
- Parkinson MPP+ assay
- MEA-based phenotypic screening
- Spontaneous network activity recording
- Compound-induced network activity recording
- Concentration-response experiments
- Substance database comparison
- Scale and capacity
- Medium-throughput screening
- Hundreds of projects
- Thousands of experiments
- Therapeutic areas
- CNS drug discovery
- Neurodegenerative diseases
- Alzheimer's disease
- Parkinson's disease
- Epilepsy
- ALS
10 more
- Schizophrenia
- Autism
- Depression
- Neuropathic pain
- Neurotoxicity
- Neuro-pharmaceuticals
- Amyotrophic lateral sclerosis (ALS)
- Fragile X syndrome
- HIV-associated neurodegenerative disorders
- Huntington's disease
Instruments and platforms
- Microelectrode array (MEA) neurochips
- Maestro MEA System from Axion Biosystems
- Automated confocal microscopy
- MEA neurochips
Modalities and species
- Modalities
- Small molecule
- Viral vector
- Species and models
- Mouse
- Rat
- Human iPSC-derived neurons
- Primary hippocampal neurons
- Primary frontal cortex cultures
- Primary midbrain neurons
13 more
- Dopaminergic neuronal cultures
- Spinal motor neurons
- Glutamatergic neurons
- GABAergic neurons
- Astrocytes
- Neural stem cells
- BrainXell Inc. spinal motor neurons
- SOD1
- C9orf72
- Human iPSC-derived cell cultures
- Primary neuronal cell cultures
- Primary mouse hippocampal neurons
- Primary mouse midbrain cultures
Industries served
- Pharmaceuticals
- Drug discovery
- Preclinical development
Company
- Type
- CRO
- Quality
- Rigorous standards (stated for screening services) · quality-controlled batches (spinal motor neuron cell batches with internal release) · standardized test protocol (MEA recordings)
Locations
- Based in
- Rostock, Germany
- Serves
- North America, Europe, Asia
Contacts
- General enquiry
- info@neuroproof.com on their site
- Phone
- +49 381 54345-660